Looking for some bad pharma news? You've come to the right place. In this story, the Wall Street Journal reports on a gloomy forecast from Severin Schwan, CEO of Roche, who predicts that some drug makers will face bankruptcy or mergers due to a lack of "innovative medicines." He is quoted as saying, "Those who fail to bring sufficient innovation will be squeezed out of this market."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.